1. Home
  2. YEXT vs XNCR Comparison

YEXT vs XNCR Comparison

Compare YEXT & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$8.13

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$15.00

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YEXT
XNCR
Founded
2006
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
YEXT
XNCR
Price
$8.13
$15.00
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$9.44
$22.78
AVG Volume (30 Days)
1.1M
772.9K
Earning Date
12-08-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$447,666,000.00
$150,132,000.00
Revenue This Year
$8.66
$18.81
Revenue Next Year
$4.77
N/A
P/E Ratio
$37.88
N/A
Revenue Growth
9.46
38.16
52 Week Low
$5.51
$6.92
52 Week High
$9.20
$24.66

Technical Indicators

Market Signals
Indicator
YEXT
XNCR
Relative Strength Index (RSI) 37.85 41.47
Support Level $8.30 $14.97
Resistance Level $8.61 $16.17
Average True Range (ATR) 0.17 0.67
MACD -0.04 -0.27
Stochastic Oscillator 13.16 2.57

Price Performance

Historical Comparison
YEXT
XNCR

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: